FLGT vs JLL · rev $156.5M vs P/E 23, rev $13.31B
Fulgent Genetics Inc (FLGT) versus Jones Lang LaSalle Incorporated (JLL) — a side-by-side from cached financials, not a winner call.
Fulgent Genetics Inc (FLGT) is a diagnostics & research company listed on US.
Jones Lang LaSalle Incorporated (JLL) is a real estate services company listed on US.
Latest reported FLGT revenue for 2026-06-30 was $156.5M. Net income was -$54.4M. FLGT currently screens at market cap $586.6M.
Latest reported JLL revenue for 2026-06-30 was $13.31B. Net income was $373.7M. JLL currently screens at market cap $12.12B and trailing P/E 23.0.
FLGT currently screens at market cap $586.6M. JLL currently screens at market cap $12.12B and trailing P/E 23.0.
Not investment advice. Open the FLGT and JLL stock pages for the full models.
Not investment advice.